Showing results (21-30 of 67) with videos related to
Sort By:
Pageof 7
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 24, 2016
Idiopathic Acquired Osteosclerosis in a Middle-Aged Woman With Systemic Lupus ErythematosusNúria Guañabens, Steven Mumm, Laia Gifre, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 30, 2011
Transient muscle paralysis degrades bone via rapid osteoclastogenesisAntonios O Aliprantis, Marina Stolina, Paul J Kostenuik, et al.Arthritis and Rheumatism|May 10, 2005
Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis modelsGeorg Schett, Scot Middleton, Brad Bolon, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 16, 2013
Novel genetic models of osteoporosis by overexpression of human RANKL in transgenic miceVagelis Rinotas, Alexandra Niti, Romain Dacquin, et al.Circulation|January 4, 2008
Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) miceSean Morony, Yin Tintut, Zina Zhang, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
Continuous RANKL inhibition in osteoprotegerin transgenic mice and rats suppresses bone resorption without impairing lymphorganogenesis or functional immune responsesMarina Stolina, Denise Dwyer, Michael S Ominsky, et al.Physiological Reports|November 10, 2021
Delayed angiopoietin-2 blockade reduces influenza-induced lung injury and improves survival in miceJeffrey E Gotts, Mazharul Maishan, Lauren Chun, et al.Frontiers in Physiology|April 19, 2021
Small Conductance Ca2 +-Activated K+ (SK) Channel mRNA Expression in Human Atrial and Ventricular Tissue: Comparison Between Donor, Atrial Fibrillation and Heart Failure TissueElisa Darkow, Thong T Nguyen, Marina Stolina, et al.Arthritis Research & Therapy|December 17, 2009
RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapiesMarina Stolina, Georg Schett, Denise Dwyer, et al.Journal of Clinical Immunology|August 30, 2008
The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritisMarina Stolina, Brad Bolon, Scot Middleton, et al.Pageof 7